Diamel

Diamel is a multi-ingredient nutritional supplement developed by Catalysis Laboratories (Madrid, Spain) intended for the management of metabolic disorders associated with insulin resistance. The formulation consists of molecularly activated amino acids, vitamins, and trace elements, including arginine, glycine, and zinc, which work synergistically to reduce oxidative stress and restore insulin sensitivity. Clinically, Diamel has been investigated as an adjunct therapy for type 2 diabetes mellitus, metabolic syndrome, polycystic ovary syndrome (PCOS), and nonalcoholic steatohepatitis (NASH). It is typically administered orally in capsule form and has demonstrated the ability to improve glycemic control, reduce glycosylated hemoglobin (HbA1c) levels, and normalize hormonal imbalances in patients with hyperinsulinemia.

Brand names

Diamel